Thermo Fisher Scientific Opens Its First Dry Powder Media Facility in APAC Region to Support Growing Biopharmaceutical Market

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SINGAPORE--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced it is expanding its global cell culture and bioprocessing capabilities by opening a new manufacturing plant in Singapore to produce dry powder media (DPM), a crucial cell culture raw material used to manufacture biologics, including vaccines, anti-cancer therapeutics, and others. The facility is the first-ever cell culture DPM production site in Singapore and is designed to address the increased global requirements from biopharmaceutical companies to mitigate critical raw material supply risks.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC